New SEC Form D filing

Avery Therapeutics, Inc., 2026-09-21

A new SEC Form D private-offering notice from Tucson, AZ, a $15,400,000 filer-stated offering target in Biotech. The source filing is one click away.

What this filing says

Avery Therapeutics, Inc. site↗ Verified via SEC Form D

Developer of immunomodulatory biologic therapeutics, including a tissue engineered heart graft for heart failure

Filed 2026-09-21Filed to raise $15,400,000First money in 2026-08-19Raised so far $8,468,859HQ (as filed) Tucson, AZSector Biotech web-verified against the company’s own siteStage (inferred) EarlyCall status Delayed filing
Source linked the Form D on EDGAR↗Website verified averythera.com↗Named in the filing 4 executives & directors
Open this row on the live feed →More new filings in Arizona →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.

Other Form D filings from the same week

each with its own page and its own EDGAR source